 | • レポートコード：MRC2-11QY04608 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はシグナル伝達阻害剤のグローバル市場について調査・分析したレポートです。種類別（ダサチニブ、エルロチニブ、ゲフィチニブ、イマチニブ、ラパチニブ、ニロチニブ、パゾパニブ、ソラフェニブ、スニチニブ）市場規模、用途別（病院薬局、小売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別シグナル伝達阻害剤の競争状況、市場シェア ・世界のシグナル伝達阻害剤市場：種類別市場規模 2015年-2020年（ダサチニブ、エルロチニブ、ゲフィチニブ、イマチニブ、ラパチニブ、ニロチニブ、パゾパニブ、ソラフェニブ、スニチニブ） ・世界のシグナル伝達阻害剤市場：種類別市場規模予測 2021年-2026年（ダサチニブ、エルロチニブ、ゲフィチニブ、イマチニブ、ラパチニブ、ニロチニブ、パゾパニブ、ソラフェニブ、スニチニブ） ・世界のシグナル伝達阻害剤市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局） ・世界のシグナル伝達阻害剤市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局） ・北米のシグナル伝達阻害剤市場分析：米国、カナダ ・ヨーロッパのシグナル伝達阻害剤市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのシグナル伝達阻害剤市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のシグナル伝達阻害剤市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのシグナル伝達阻害剤市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bristol-Myers Squibb、Roche、AstraZeneca、GSK、Novartis、Amgen、Pfizer ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Signal transduction inhibitors are drugs that may prevent the ability of cancer cells to multiply quickly and invade other tissues.
Growing need for effective cancer diagnostics and innovative therapies for cancer treatment are expected to be the major factors driving the signal transduction inhibitors market.
Market Analysis and Insights: Global Signal Transduction Inhibitors Market
The global Signal Transduction Inhibitors market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Signal Transduction Inhibitors Scope and Market Size
Signal Transduction Inhibitors market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Signal Transduction Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Bristol-Myers Squibb
Roche
AstraZeneca
GSK
Novartis
Amgen
Pfizer
…
Market segment by Type, the product can be split into
Dasatinib
Erlotinib
Gefitinib
Imatinib
Lapatinib
Nilotinib
Pazopanib
Sorafenib
Sunitinib
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Signal Transduction Inhibitors Revenue
1.4 Market by Type
1.4.1 Global Signal Transduction Inhibitors Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Dasatinib
1.4.3 Erlotinib
1.4.4 Gefitinib
1.4.5 Imatinib
1.4.6 Lapatinib
1.4.7 Nilotinib
1.4.8 Pazopanib
1.4.9 Sorafenib
1.4.10 Sunitinib
1.5 Market by Application
1.5.1 Global Signal Transduction Inhibitors Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Signal Transduction Inhibitors Market Perspective (2015-2026)
2.2 Global Signal Transduction Inhibitors Growth Trends by Regions
2.2.1 Signal Transduction Inhibitors Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Signal Transduction Inhibitors Historic Market Share by Regions (2015-2020)
2.2.3 Signal Transduction Inhibitors Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Signal Transduction Inhibitors Market Growth Strategy
2.3.6 Primary Interviews with Key Signal Transduction Inhibitors Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Signal Transduction Inhibitors Players by Market Size
3.1.1 Global Top Signal Transduction Inhibitors Players by Revenue (2015-2020)
3.1.2 Global Signal Transduction Inhibitors Revenue Market Share by Players (2015-2020)
3.1.3 Global Signal Transduction Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Signal Transduction Inhibitors Market Concentration Ratio
3.2.1 Global Signal Transduction Inhibitors Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Signal Transduction Inhibitors Revenue in 2019
3.3 Signal Transduction Inhibitors Key Players Head office and Area Served
3.4 Key Players Signal Transduction Inhibitors Product Solution and Service
3.5 Date of Enter into Signal Transduction Inhibitors Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Signal Transduction Inhibitors Historic Market Size by Type (2015-2020)
4.2 Global Signal Transduction Inhibitors Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Signal Transduction Inhibitors Market Size by Application (2015-2020)
5.2 Global Signal Transduction Inhibitors Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Signal Transduction Inhibitors Market Size (2015-2020)
6.2 Signal Transduction Inhibitors Key Players in North America (2019-2020)
6.3 North America Signal Transduction Inhibitors Market Size by Type (2015-2020)
6.4 North America Signal Transduction Inhibitors Market Size by Application (2015-2020)
7 Europe
7.1 Europe Signal Transduction Inhibitors Market Size (2015-2020)
7.2 Signal Transduction Inhibitors Key Players in Europe (2019-2020)
7.3 Europe Signal Transduction Inhibitors Market Size by Type (2015-2020)
7.4 Europe Signal Transduction Inhibitors Market Size by Application (2015-2020)
8 China
8.1 China Signal Transduction Inhibitors Market Size (2015-2020)
8.2 Signal Transduction Inhibitors Key Players in China (2019-2020)
8.3 China Signal Transduction Inhibitors Market Size by Type (2015-2020)
8.4 China Signal Transduction Inhibitors Market Size by Application (2015-2020)
9 Japan
9.1 Japan Signal Transduction Inhibitors Market Size (2015-2020)
9.2 Signal Transduction Inhibitors Key Players in Japan (2019-2020)
9.3 Japan Signal Transduction Inhibitors Market Size by Type (2015-2020)
9.4 Japan Signal Transduction Inhibitors Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Signal Transduction Inhibitors Market Size (2015-2020)
10.2 Signal Transduction Inhibitors Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Signal Transduction Inhibitors Market Size by Type (2015-2020)
10.4 Southeast Asia Signal Transduction Inhibitors Market Size by Application (2015-2020)
11 India
11.1 India Signal Transduction Inhibitors Market Size (2015-2020)
11.2 Signal Transduction Inhibitors Key Players in India (2019-2020)
11.3 India Signal Transduction Inhibitors Market Size by Type (2015-2020)
11.4 India Signal Transduction Inhibitors Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Signal Transduction Inhibitors Market Size (2015-2020)
12.2 Signal Transduction Inhibitors Key Players in Central & South America (2019-2020)
12.3 Central & South America Signal Transduction Inhibitors Market Size by Type (2015-2020)
12.4 Central & South America Signal Transduction Inhibitors Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Bristol-Myers Squibb
13.1.1 Bristol-Myers Squibb Company Details
13.1.2 Bristol-Myers Squibb Business Overview
13.1.3 Bristol-Myers Squibb Signal Transduction Inhibitors Introduction
13.1.4 Bristol-Myers Squibb Revenue in Signal Transduction Inhibitors Business (2015-2020))
13.1.5 Bristol-Myers Squibb Recent Development
13.2 Roche
13.2.1 Roche Company Details
13.2.2 Roche Business Overview
13.2.3 Roche Signal Transduction Inhibitors Introduction
13.2.4 Roche Revenue in Signal Transduction Inhibitors Business (2015-2020)
13.2.5 Roche Recent Development
13.3 AstraZeneca
13.3.1 AstraZeneca Company Details
13.3.2 AstraZeneca Business Overview
13.3.3 AstraZeneca Signal Transduction Inhibitors Introduction
13.3.4 AstraZeneca Revenue in Signal Transduction Inhibitors Business (2015-2020)
13.3.5 AstraZeneca Recent Development
13.4 GSK
13.4.1 GSK Company Details
13.4.2 GSK Business Overview
13.4.3 GSK Signal Transduction Inhibitors Introduction
13.4.4 GSK Revenue in Signal Transduction Inhibitors Business (2015-2020)
13.4.5 GSK Recent Development
13.5 Novartis
13.5.1 Novartis Company Details
13.5.2 Novartis Business Overview
13.5.3 Novartis Signal Transduction Inhibitors Introduction
13.5.4 Novartis Revenue in Signal Transduction Inhibitors Business (2015-2020)
13.5.5 Novartis Recent Development
13.6 Amgen
13.6.1 Amgen Company Details
13.6.2 Amgen Business Overview
13.6.3 Amgen Signal Transduction Inhibitors Introduction
13.6.4 Amgen Revenue in Signal Transduction Inhibitors Business (2015-2020)
13.6.5 Amgen Recent Development
13.7 Pfizer
13.7.1 Pfizer Company Details
13.7.2 Pfizer Business Overview
13.7.3 Pfizer Signal Transduction Inhibitors Introduction
13.7.4 Pfizer Revenue in Signal Transduction Inhibitors Business (2015-2020)
13.7.5 Pfizer Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Signal Transduction Inhibitors Key Market Segments
Table 2. Key Players Covered: Ranking by Signal Transduction Inhibitors Revenue
Table 3. Ranking of Global Top Signal Transduction Inhibitors Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Signal Transduction Inhibitors Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Dasatinib
Table 6. Key Players of Erlotinib
Table 7. Key Players of Gefitinib
Table 8. Key Players of Imatinib
Table 9. Key Players of Lapatinib
Table 10. Key Players of Nilotinib
Table 11. Key Players of Pazopanib
Table 12. Key Players of Sorafenib
Table 13. Key Players of Sunitinib
Table 14. Global Signal Transduction Inhibitors Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Signal Transduction Inhibitors Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Signal Transduction Inhibitors Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Signal Transduction Inhibitors Market Share by Regions (2015-2020)
Table 18. Global Signal Transduction Inhibitors Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Signal Transduction Inhibitors Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Signal Transduction Inhibitors Market Growth Strategy
Table 24. Main Points Interviewed from Key Signal Transduction Inhibitors Players
Table 25. Global Signal Transduction Inhibitors Revenue by Players (2015-2020) (Million US$)
Table 26. Global Signal Transduction Inhibitors Market Share by Players (2015-2020)
Table 27. Global Top Signal Transduction Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Signal Transduction Inhibitors as of 2019)
Table 28. Global Signal Transduction Inhibitors by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Signal Transduction Inhibitors Product Solution and Service
Table 31. Date of Enter into Signal Transduction Inhibitors Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Signal Transduction Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 34. Global Signal Transduction Inhibitors Market Size Share by Type (2015-2020)
Table 35. Global Signal Transduction Inhibitors Revenue Market Share by Type (2021-2026)
Table 36. Global Signal Transduction Inhibitors Market Size Share by Application (2015-2020)
Table 37. Global Signal Transduction Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 38. Global Signal Transduction Inhibitors Market Size Share by Application (2021-2026)
Table 39. North America Key Players Signal Transduction Inhibitors Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Signal Transduction Inhibitors Market Share (2019-2020)
Table 41. North America Signal Transduction Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 42. North America Signal Transduction Inhibitors Market Share by Type (2015-2020)
Table 43. North America Signal Transduction Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 44. North America Signal Transduction Inhibitors Market Share by Application (2015-2020)
Table 45. Europe Key Players Signal Transduction Inhibitors Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Signal Transduction Inhibitors Market Share (2019-2020)
Table 47. Europe Signal Transduction Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Signal Transduction Inhibitors Market Share by Type (2015-2020)
Table 49. Europe Signal Transduction Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Signal Transduction Inhibitors Market Share by Application (2015-2020)
Table 51. China Key Players Signal Transduction Inhibitors Revenue (2019-2020) (Million US$)
Table 52. China Key Players Signal Transduction Inhibitors Market Share (2019-2020)
Table 53. China Signal Transduction Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 54. China Signal Transduction Inhibitors Market Share by Type (2015-2020)
Table 55. China Signal Transduction Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 56. China Signal Transduction Inhibitors Market Share by Application (2015-2020)
Table 57. Japan Key Players Signal Transduction Inhibitors Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Signal Transduction Inhibitors Market Share (2019-2020)
Table 59. Japan Signal Transduction Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Signal Transduction Inhibitors Market Share by Type (2015-2020)
Table 61. Japan Signal Transduction Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Signal Transduction Inhibitors Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Signal Transduction Inhibitors Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Signal Transduction Inhibitors Market Share (2019-2020)
Table 65. Southeast Asia Signal Transduction Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Signal Transduction Inhibitors Market Share by Type (2015-2020)
Table 67. Southeast Asia Signal Transduction Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Signal Transduction Inhibitors Market Share by Application (2015-2020)
Table 69. India Key Players Signal Transduction Inhibitors Revenue (2019-2020) (Million US$)
Table 70. India Key Players Signal Transduction Inhibitors Market Share (2019-2020)
Table 71. India Signal Transduction Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 72. India Signal Transduction Inhibitors Market Share by Type (2015-2020)
Table 73. India Signal Transduction Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 74. India Signal Transduction Inhibitors Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Signal Transduction Inhibitors Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Signal Transduction Inhibitors Market Share (2019-2020)
Table 77. Central & South America Signal Transduction Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Signal Transduction Inhibitors Market Share by Type (2015-2020)
Table 79. Central & South America Signal Transduction Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Signal Transduction Inhibitors Market Share by Application (2015-2020)
Table 81. Bristol-Myers Squibb Company Details
Table 82. Bristol-Myers Squibb Business Overview
Table 83. Bristol-Myers Squibb Product
Table 84. Bristol-Myers Squibb Revenue in Signal Transduction Inhibitors Business (2015-2020) (Million US$)
Table 85. Bristol-Myers Squibb Recent Development
Table 86. Roche Company Details
Table 87. Roche Business Overview
Table 88. Roche Product
Table 89. Roche Revenue in Signal Transduction Inhibitors Business (2015-2020) (Million US$)
Table 90. Roche Recent Development
Table 91. AstraZeneca Company Details
Table 92. AstraZeneca Business Overview
Table 93. AstraZeneca Product
Table 94. AstraZeneca Revenue in Signal Transduction Inhibitors Business (2015-2020) (Million US$)
Table 95. AstraZeneca Recent Development
Table 96. GSK Company Details
Table 97. GSK Business Overview
Table 98. GSK Product
Table 99. GSK Revenue in Signal Transduction Inhibitors Business (2015-2020) (Million US$)
Table 100. GSK Recent Development
Table 101. Novartis Company Details
Table 102. Novartis Business Overview
Table 103. Novartis Product
Table 104. Novartis Revenue in Signal Transduction Inhibitors Business (2015-2020) (Million US$)
Table 105. Novartis Recent Development
Table 106. Amgen Company Details
Table 107. Amgen Business Overview
Table 108. Amgen Product
Table 109. Amgen Revenue in Signal Transduction Inhibitors Business (2015-2020) (Million US$)
Table 110. Amgen Recent Development
Table 111. Pfizer Company Details
Table 112. Pfizer Business Overview
Table 113. Pfizer Product
Table 114. Pfizer Revenue in Signal Transduction Inhibitors Business (2015-2020) (Million US$)
Table 115. Pfizer Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Signal Transduction Inhibitors Market Share by Type: 2020 VS 2026
Figure 2. Dasatinib Features
Figure 3. Erlotinib Features
Figure 4. Gefitinib Features
Figure 5. Imatinib Features
Figure 6. Lapatinib Features
Figure 7. Nilotinib Features
Figure 8. Pazopanib Features
Figure 9. Sorafenib Features
Figure 10. Sunitinib Features
Figure 11. Global Signal Transduction Inhibitors Market Share by Application: 2020 VS 2026
Figure 12. Hospital Pharmacies Case Studies
Figure 13. Retail Pharmacies Case Studies
Figure 14. Signal Transduction Inhibitors Report Years Considered
Figure 15. Global Signal Transduction Inhibitors Market Size YoY Growth 2015-2026 (US$ Million)
Figure 16. Global Signal Transduction Inhibitors Market Share by Regions: 2020 VS 2026
Figure 17. Global Signal Transduction Inhibitors Market Share by Regions (2021-2026)
Figure 18. Porter's Five Forces Analysis
Figure 19. Global Signal Transduction Inhibitors Market Share by Players in 2019
Figure 20. Global Top Signal Transduction Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Signal Transduction Inhibitors as of 2019
Figure 21. The Top 10 and 5 Players Market Share by Signal Transduction Inhibitors Revenue in 2019
Figure 22. North America Signal Transduction Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Europe Signal Transduction Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. China Signal Transduction Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Japan Signal Transduction Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Southeast Asia Signal Transduction Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. India Signal Transduction Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Central & South America Signal Transduction Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Bottom-up and Top-down Approaches for This Report
Figure 30. Data Triangulation
Figure 31. Key Executives Interviewed
ベクトル信号発生器の世界市場（～2026年） Vector signal generator is a test and measurement equipment used for testing complex waveforms. This equipment was developed considering the emergence of new communication technologies and consists of a high-end radio-frequency (RF) signal generator with an IQ modulator. According to the report, the…- シグナルリピーターの世界市場（～2026年） In telecommunications, a repeater is an electronic device that receives a signal and retransmits it. Rapid development of the telecommunication industry is the major factor spurring the growth of the signal repeater market during the forecast period. Market Analysis and Insights: Global Signal Repea…
- 鉄道信号専用機器の世界市場（～2026年） Technical equipment on railways to ensure the safety of running and shunting operations, improve the passing capacity of stations and sections, train unbraiding capacity, and improve the working conditions of operators Market Analysis and Insights: Global Railway Signal Special Equipment Market The …
- アナログ・ミックスドシグナルIPの世界市場（～2026年） Increasing technological focus and investments from market leaders in this region are driving this market, making it the the largest market for AMS IP. The growing number of players in the North American region have resulted in increasing collaboration, which leads to growing technology. Europe is t…
- 携帯電話信号遮蔽装置の世界市場（～2026年） Mobile phone signal shielding devices offer effective and efficient cell phone radiation protection for multiple purposes. The global mobile phone signal shielding device market is driven by an enormous increase in mobile phone usage globally. In addition, rise in electromagnetic pollution, which is…